Literature DB >> 16358443

The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.

Klaus M Leisinger.   

Abstract

In recent years society has come to expect more from the "socially-responsible" company and the global HIV/AIDS pandemic in particular has resulted in some critics saying that the "Big Pharma" companies have not been living up to their social responsibilities. Corporate social responsibility can be understood as the socio-economic product of the organizational division of labor in complex modern society. Global poverty and poor health conditions are in the main the responsibilities of the world's national governments and international governmental organizations, which possess society's mandate and appropriate organizational capabilities. Private enterprises have neither the societal mandate nor the organizational capabilities to feed the poor or provide health care to the sick in their home countries or in the developing world. Nevertheless, private enterprises do have responsibilities to society that can be categorized as what they must do, what they ought do, and what they can do.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2005        PMID: 16358443     DOI: 10.5840/beq200515440

Source DB:  PubMed          Journal:  Bus Ethics Q        ISSN: 1052-150X


  10 in total

1.  Restoring a reputation: invoking the UNESCO Universal Declaration on Bioethics and Human Rights to bear on pharmaceutical pricing.

Authors:  Daniel J Hurst
Journal:  Med Health Care Philos       Date:  2017-03

2.  Drug companies should be held more accountable for their human rights responsibilities.

Authors: 
Journal:  PLoS Med       Date:  2010-09-28       Impact factor: 11.069

3.  Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program.

Authors:  Taryn Vian; Sarah C Richards; Kelly McCoy; Patrick Connelly; Frank Feeley
Journal:  Hum Resour Health       Date:  2007-03-02

Review 4.  Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.

Authors:  Hayley Droppert; Sara Bennett
Journal:  Global Health       Date:  2015-04-09       Impact factor: 4.185

5.  Industry, innovation and social values.

Authors:  Harvey E Bale
Journal:  Sci Eng Ethics       Date:  2005-01       Impact factor: 3.525

6.  Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market.

Authors:  Tatiana Dănescu; Maria-Alexandra Popa
Journal:  Global Health       Date:  2020-12-10       Impact factor: 4.185

7.  Corporate social responsibility of pharmaceutical industry in Korea.

Authors:  Green Bae; Jeong-Hoon Ahn; Kyung-Min Lim; SeungJin Bae
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

Review 8.  'Public enemy no. 1': Tobacco industry funding for the AIDS response.

Authors:  Julia Smith; Sheryl Thompson; Kelley Lee
Journal:  SAHARA J       Date:  2016

9.  Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.

Authors:  Ye Lim Jung; JeeNa Hwang; Hyoung Sun Yoo
Journal:  Global Health       Date:  2020-09-10       Impact factor: 4.185

10.  COPD management as a model for all chronic respiratory conditions: report of the 4th Consensus Conference in Respiratory Medicine.

Authors:  Stefano Nardini; Fernando De Benedetto; Claudio M Sanguinetti; Salvatore Bellofiore; Stefano Carlone; Salvatore Privitera; Luciano Sagliocca; Emmanuele Tupputi; Claudio Baccarani; Gennaro Caiffa; Maria Consiglia Calabrese; Antonio Capuozzo; Salvatore Cauchi; Valentina Conio; Giuseppe Coratella; Franco Crismancich; Roberto W Dal Negro; Franco Dellarole; Maurizio Delucchi; Carlo Favaretti; Silvia Forte; Franca Matilde Gallo; Riccardo Giuliano; Marco Grandi; Antonino Grillo; Maria Rosaria Gualano; Enrico Guffanti; Salvatore Locicero; Francesco Paolo Lombardo; Marco Mantero; Roberto Marasso; Laura Martino; Michele Mastroberardino; Carlo Mereu; Roberto Messina; Margherita Neri; Bruno Franco Novelletto; Paolo Parente; Sergio Pasquinucci; Massimo Pistolesi; Mario Polverino; Agnese Posca; Luca Richeldi; Fernando Roccia; Ettore Saffi Giustini; Michelangelo Salemi; Salvatore Santacroce; Mario Schisano; Matteo Schisano; Eleonora Selvi; Andrea Silenzi; Patrizio Soverina; Claudio Taranto; Marta Ugolini; Piero Visaggi; Alessandro Zanasi
Journal:  Multidiscip Respir Med       Date:  2017-11-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.